Yusuf Oğuz

Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease

Mehmet Kanbay, Yalçın Solak, Hilmi Umut Ünal et al. · International Urology and Nephrology · 2014 · 278 citations

Medicine, Nephrology, Renal Pathophysiology +10

FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease

Alper Sönmez, Mutlu Sağlam, Halıl Yaman et al. · Kidney International · 2010 · 162 citations · Full text

Medicine, Molecular Medicine, Nephrology +13

Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease

Dimitrie Siriopol, Mutlu Sağlam, Yasemin Gülcan Kurt et al. · Kidney International · 2014 · 151 citations

Veterinary Medicine, Nephrology, Physiology +17

Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial

Mahmut İlker Yılmaz, Alper Sönmez, Mutlu Sağlam et al. · American Journal of Kidney Diseases · 2011 · 136 citations

Medicine, Nephrology, Calcium Homeostasis +11

Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients

Kayser Çağlar, Mahmut İlker Yılmaz, Mutlu Sağlam et al. · Clinical Journal of the American Society of Nephrology · 2007 · 131 citations

Medicine, Nephrology, Pharmacotherapy +15